By re-examining subjects from the population-based Malmo Diet and Cancer Study cardiovascular cohort, Enhörning et al. showed that increasing copeptin levels were associated with an increasing incidence of abdominal obesity, T2D and microalbuminuria, suggesting a relationship between AVP and cardiometabolic risk [42]. This evidence concerns the gene AVP and cancer.